425P - CHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma.
Saved in:
| Title: | 425P - CHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma. |
|---|---|
| Authors: | Compter, I.1 (AUTHOR), Eekers, D.1 (AUTHOR), Hoeben, A.2 (AUTHOR), Rouschop, K.1 (AUTHOR), Reymen, B.J.1 (AUTHOR), Ackermans, L.3 (AUTHOR), Beckervordersantforth, J.4 (AUTHOR), Bauer, N.5 (AUTHOR), Anten, M.6 (AUTHOR), Wesseling, P.7 (AUTHOR), Postma, A.8 (AUTHOR), De Ruysscher, D.1 (AUTHOR), Lambin, P.9 (AUTHOR) |
| Source: | Annals of Oncology. 2019 Supplement 6, Vol. 30, pv154-v154. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdz243.035 |
